RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis.
assessment
asthma
daily practice
paediatrics
quality of life
rhinitis
Journal
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
ISSN: 1365-2222
Titre abrégé: Clin Exp Allergy
Pays: England
ID NLM: 8906443
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
23
11
2019
revised:
13
02
2020
accepted:
08
03
2020
pubmed:
13
3
2020
medline:
12
8
2021
entrez:
13
3
2020
Statut:
ppublish
Résumé
RhinAsthma Patient Perspective (RAPP) is a short, validated questionnaire for assessing health-related quality of life (HRQoL) in adult patients with comorbid asthma and rhinitis, while a paediatric version is still not available. The current study aimed to develop and validate the RAPP-children questionnaire. RAPP-children was derived by combining RhinAsthma-children subscales into five unique items. At baseline (T0) and after 30 days (T1), 150 children (6-11 years) with comorbid asthma (predominantly intermittent or mild persistent) and rhinitis were given the following: RAPP-children, RhinAsthma-children, Paediatric Asthma Quality of Life Questionnaire (PAQLQ, age >6 years), Paediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ), Childhood Asthma Control Test (CACT), KiddyKindl RAPP-children fairly reproduced RhinAsthma-children scores (concordance correlation coefficients between 0.91 and 0.95). RAPP-children showed adequate convergent validity (absolute Spearman's rho larger than 0.5 with PAQLQ, PRQLQ, CACT, KiddyKindl/KidKindl, and VAS), internal consistency (Cronbach's alpha > 0.70), repeatability (intra-cluster correlation coefficient between 0.61 and 0.8) in the presence of clinical stability (GRC = 0), discriminant validity (sensitivity to asthma control status and rhinitis severity), and sensitivity to symptom improvements (GRC > 1). The minimal important difference (MID) was -20. Floor and ceiling effects were minimal. RAPP-children showed fair usability also in younger children (6-8 years). RAPP-children is a valid, five-item questionnaire for assessing HRQoL in children aged 6 to 11 years with concomitant asthma and rhinitis. Although further investigation is required in moderate and severe asthmatics, this tool can be useful in clinical trials and in routine medical practice for improving the management of respiratory allergy in children.
Sections du résumé
BACKGROUND
RhinAsthma Patient Perspective (RAPP) is a short, validated questionnaire for assessing health-related quality of life (HRQoL) in adult patients with comorbid asthma and rhinitis, while a paediatric version is still not available.
OBJECTIVE
The current study aimed to develop and validate the RAPP-children questionnaire.
METHODS
RAPP-children was derived by combining RhinAsthma-children subscales into five unique items. At baseline (T0) and after 30 days (T1), 150 children (6-11 years) with comorbid asthma (predominantly intermittent or mild persistent) and rhinitis were given the following: RAPP-children, RhinAsthma-children, Paediatric Asthma Quality of Life Questionnaire (PAQLQ, age >6 years), Paediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ), Childhood Asthma Control Test (CACT), KiddyKindl
RESULTS
RAPP-children fairly reproduced RhinAsthma-children scores (concordance correlation coefficients between 0.91 and 0.95). RAPP-children showed adequate convergent validity (absolute Spearman's rho larger than 0.5 with PAQLQ, PRQLQ, CACT, KiddyKindl/KidKindl, and VAS), internal consistency (Cronbach's alpha > 0.70), repeatability (intra-cluster correlation coefficient between 0.61 and 0.8) in the presence of clinical stability (GRC = 0), discriminant validity (sensitivity to asthma control status and rhinitis severity), and sensitivity to symptom improvements (GRC > 1). The minimal important difference (MID) was -20. Floor and ceiling effects were minimal. RAPP-children showed fair usability also in younger children (6-8 years).
CONCLUSION & CLINICAL RELEVANCE
RAPP-children is a valid, five-item questionnaire for assessing HRQoL in children aged 6 to 11 years with concomitant asthma and rhinitis. Although further investigation is required in moderate and severe asthmatics, this tool can be useful in clinical trials and in routine medical practice for improving the management of respiratory allergy in children.
Banques de données
ClinicalTrials.gov
['NCT03276416']
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
662-671Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Baiardini I, Bousquet P, Brzoza Z, et al. Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper. Allergy. 2010;65:290-295.
Everhart RS, Fiese BH. Asthma severity and child quality of life in pediatric asthma: a systematic review. Patient Educ Couns. 2009;75:162-168.
Wintner LM, Giesinger JM, Kemmler G, et al. The benefits of using patient-reported outcomes in cancer treatment: an overview. Wien Klin Wochenschr. 2012;124:293-303.
Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13:211.
Fargas-Malet M, McSherry D, Larkin E, Robinson C. Research with children: Methodological issues and innovative techniques. J Early Child Res. 2010;8:175-192.
Morgan M, Gibbs S, Maxwell K, Britten N. Hearing children’s voices: methodological issues in conducting focus groups with children aged 7-11 years. Qual Res. 2002;2:5-20.
Borgers N, De Leeuw E, Hox J. Children as respondents in survey research: Cognitive development and response quality. Bull Sociol Methodol. 2000;66:60-75.
Arbuckle R, Abetz-Webb L. “Not just little adults”: qualitative methods to support the development of pediatric patient-reported outcomes. Patient. 2013;6:143-159.
Holaday B, Turner-Henson A. Response effects in surveys with school-age children. Nurs Res. 1989;38:248-250.
Borgers N, Hox J. Item nonresponse in questionnaire research with children. J Off Stat. 2001;17:321.
Cole CB, Loftus EF. The memory of children. In: Ceci SJ, Toglia MP, Ross DF, eds. Children’s eyewitness memory. New York: Springer; 1987: 178-208.
Bell A. Designing and testing questionnaires for children. J Res Nurs. 2007;12:461-469.
Braido F, Bousquet P, Brzoza Z, et al. Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper. Allergy. 2010;65:959-968.
Braido F, Baiardini I, Balestracci S, et al. Does asthma control correlate with quality of life related to upper and lower airways? A real life study. Allergy. 2009;64:937-943.
Cibella F, Ferrante G, Cuttitta G, et al. The burden of rhinitis and rhinoconjunctivitis in adolescents. Allergy Asthma Immunol Res. 2015;7:44-50.
Licari A, Castagnoli R, Denicolò CF, Rossini L, Marseglia A, Marseglia GL. The nose and the lung: united airway disease? Front Pediatr. 2017;5:44.
Juniper EF, Guyatt GH, Feeny DH, Ferrie P, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996;5:35-46.
Juniper EF, Howland WC, Robertsa NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163-170.
Braido F, Baiardini I, Stagi E, et al. RhinAsthma Patient Perspective: a short daily asthma and rhinitis QoL assessment. Allergy. 2012;67:1443-1450.
Lim MC, Baiardini I, Molinengo G, Navarro-Locsin CG, Canonica GW, Braido F. The cross-cultural validation of the English version of RhinAsthma patient’s perspective (RAPP). J Asthma. 2019;1-7.
Todo-Bom A, Braido F, Molinengo G, Loureiro C, Canonica GW, Baiardini I. The Portuguese version of Rhinitis and Asthma Patient’s Perspective (RAPP): Validation and assessment. Pulmonology. 2019;26(2):73-77.
Ansotegui I, Braido F, Molinengo G, et al. Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in Spanish. Allergol Immunopathol (Madr). 2019;48(2):165-169.
La Grutta S, Landi M, Braido F, et al. RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy. Pediatr Allergy Immunol. 2014;25:450-455.
Baiardini I, Fasola S, Montalbano L, et al. RHINASTHMA-Children: A new quality of life tool for patients with respiratory allergy. Pediatr Allergy Immunol. 2017;28:102-105.
Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention, 2018. Available at http://ginasthma.org.
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008. Allergy. 2008;63:8-160.
Koolen B, Pijnenburg M, Brackel H, et al. Comparing global initiative for asthma (GINA) criteria with the childhood asthma control test (C-ACT) and asthma control test (ACT). Eur Respir J. 2011;38:561-566.
Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119:817-825.
Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res. 1998;7:399-407.
Bousquet P, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62:367-372.
Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27:26-35.
Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Int J Test. 2005;5:159-168.
McBride G.A proposal for strength-of-agreement criteria for Lin’s concordance correlation coefficient. NIWA Client Rep HAM2005-062. 2005.
Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum; 1988.
Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
Kramer MS, Feinstein AR. Clinical biostatistics: LIV. The biostatistics of concordance. Clin Pharmacol Ther. 1981;29:111-123.
Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34-42.
Zou G. Sample size formulas for estimating intraclass correlation coefficients with precision and assurance. Stat Med. 2012;31:3972-3981.
Linhares DV, Fonseca JAL, Borrego LM, et al. Validation of control of allergic rhinitis and asthma test for children (CARATKids)-a prospective multicenter study. Pediatr Allergy Immunol. 2014;25:173-179.
Borrego LM, Fonseca JA, Pereira AM, Pinto VR, Linhares D, Morais-Almeida M. Development process and cognitive testing of CARATkids-Control of Allergic Rhinitis and Asthma Test for children. BMC Pediatr. 2014;14:34.
Janson H. Influences on participation rate in a national Norwegian child development screening questionnaire study. Acta Paediatr. 2003;92:91-96.
Cilluffo G, Fasola S, Ferrante G, et al. Overrating classifier performance in ROC analysis in the absence of a test set: evidence from simulation and Italian CARATkids validation. Methods Inf Med. 2019;58:e27-e42.